focus -WSS

focus

author：entertainment 2025-09-29 03:24:30 - browse：21

Fran van Delft for Galapagos

Seeking to differentiate itself from other makers of CAR-T cancer therapies, Galapagos NV on Wednesday announced it had struck a deal with Blood Centers of America to open up dozens of manufacturing sites for its cell-based medicines around the U.S.

Galapagos said it will rely on the partnership, the financial terms of which were not disclosed, as it moves its CAR-Ts for different cancers into pivotal studies and could also help launch those medicines should they win approval. The Belgian company framed the collaboration as one that could help overcome the limitations that have held back access to existing CAR-T therapies from other companies.

CAR-Ts have proven to be potent treatments for certain cancers, but they are complicated medicines to make. Immune cells have to be removed from a patient, shipped to specialty sites, where they’re engineered with cancer-killing abilities, and then returned to the hospital for infusion back into patients. The process, which can take weeks if not months, has put a crunch on the number of patients companies and hospitals are able to treat.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： New brain studies show LSD's effects on the brain in full color

Wikipedia

WSS

What's changing in Medicare's open enrollment this year?

AI generated plenty of interest at JPM but not a lot of trust

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Biotech venture capitalists face new demands from investors

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

My yearlong odyssey to get my son’s ADHD medication covered

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Elizabeth Holmes banned from government health programs

Jerome Adams on the need for new antivirals for Covid

European regulators consider appeal over Amylyx ALS drug

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FDA clears AI tool for detecting skin cancer

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Prior authorization will have to move faster under new Biden rule

Affirmative action in medical school literally saved lives

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Wikipedia

Copay coupons to count toward deductibles, after Biden court move

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

There’s no way to know how good AI health technologies are

Female surgeons have lower rates of long

STAT Readout Newsletter: Today in biotech, life science news

leisure time

Wikipedia

Wikipedia

Wikipedia